Fortress Biotech, Inc. FBIO

2.28 0.00 0.00% as of 25 Sep
Market cap
$76.0M
P/E
0.7×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
1.61 0.73 0.26 0.76 2.97 5.01 3.84 1.39 9.84 6.79
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(8.14) (3.27) (0.62) (1.21) (5.28) (11.15) (5.62) (1.69) (8.13) (6.23)
P/B ratio
1.64 0.00 13.77 1.15 0.90 1.16 1.94 1.89 1.41 1.35
Price to Tangible BV
2.95 0.00 0.00 2.53 0.96 1.25 2.16 2.04 1.42 2.39
EV/Sales
1.25 0.90 0.13 (0.32) (0.79) 1.24 2.60 0.55 5.10 2.82
EV/EBITDA
0.00 0.00 0.00 0.13 0.30 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(1.20) (0.65) (0.09) 0.14 0.46 (0.68) (1.00) (0.15) (1.08) (1.01)
EV/FCF
(0.75) (0.44) (0.07) 0.12 0.41 (0.62) (0.90) (0.14) (1.03) (0.82)
Quick Ratio
2.20 0.95 1.13 1.62 3.26 4.99 3.32 1.63 1.95 1.77
Current Ratio
2.49 1.27 1.38 1.80 3.43 5.14 3.43 2.00 2.56 1.94
Net Debt/EBITDA
0.43 (0.01) 0.15 0.43 1.45 2.01 0.44 0.03 0.80 1.01
Debt/Assets
28.25% 40.19% 36.33% 32.65% 11.95% 19.85% 40.38% 56.39% 25.41% 16.53%
Debt/Equity
0.84 (35.26) 38.35 1.92 0.21 0.34 1.26 4.03 0.52 0.34
Asset Turnover
0.38 0.37 0.37 0.22 0.19 0.16 0.20 0.14 0.08 0.11
Operating CF/Net income
34.95 1.43 1.87 1.90 1.80 1.80 2.38 1.17 1.22 0.83
Capex/Depreciation
0.15 (1.60) (0.19) (0.26) (1.53) (0.65) (1.18) (2.09) (0.91) (3.81)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(6.22%) 177,428.57% (266.13%) (68.58%) (30.60%) (34.52%) (86.61%) (120.00%) (65.74%) (65.89%)
ROA
(1.14%) (35.86%) (29.74%) (27.39%) (17.73%) (16.62%) (21.75%) (43.49%) (32.10%) (38.08%)
ROIC
(124.61%) 0.00% 0.00% 0.00% 0.00% (197.50%) (255.54%) (464.85%) (107.83%) (210.59%)
Return on Tangible Assets
(2.46%) (251.39%) (177.81%) (81.74%) (24.84%) (20.56%) (32.47%) (124.46%) (56.26%) (91.15%)
Average Days of Receivables
172.75 65.83 66.46 136.60 126.23 197.49 143.53 103.10 177.28 192.44
Research and Development Expense of Revenue
18.81% 98.62% 125.51% 178.07% 187.33% 140.59% 222.03% 325.06% 304.35% 213.19%
Selling, General and Administrative Expense of Revenue
152.38% 152.11% 107.65% 150.05% 126.24% 134.14% 151.76% 198.54% 295.14% 208.24%
Intangible Assets out of Total Assets
0.15 0.22 0.12 0.09 0.03 0.04 0.03 0.01 0.00 0.21
Share Based Compensation of Revenue
45.43% 56.75% 21.93% 30.35% 29.52% 32.53% 43.45% 67.38% 85.21% 83.80%
Graham Net Nets
0.00 (1.32) (2.24) (0.24) 0.86 0.57 0.02 (0.27) 0.34 0.20
Graham Number
0.00 2.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(2.19%) (154.23%) (338.45%) (149.16%) (31.58%) (20.18%) (27.22%) (263.32%) (39.54%) (48.90%)
Free Cash Flow Yield
(102.44%) (278.92%) (690.76%) (350.93%) (65.13%) (40.33%) (75.03%) (289.35%) (50.38%) (50.31%)
Revenue per Share
2.27 2.78 10.42 12.78 12.62 9.49 10.04 9.27 6.21 6.18
Operating CF per Share
(2.36) (3.86) (15.81) (30.28) (21.39) (17.42) (26.02) (34.10) (29.26) (17.19)
Capex per Share
0.04 (0.72) (0.26) (0.49) (3.00) (1.49) (2.57) (3.23) (1.44) (3.94)
Free Cash Flow per Share
(2.32) (4.58) (16.07) (30.77) (24.39) (18.92) (28.60) (37.33) (30.70) (21.13)
Cash per Share
2.85 2.76 9.98 30.09 56.11 48.59 37.50 28.67 47.13 34.40
Shareholders Equity per Share
2.23 (0.08) 0.20 8.44 41.45 41.02 19.88 6.81 43.37 31.13
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
2.23 (0.08) 0.20 8.44 41.45 41.02 19.88 6.81 43.37 31.13
Free Cash Flow
(64.61) (95.19) (130.32) (182.33) (132.89) (90.85) (104.36) (108.20) (85.32) (56.32)
Working Capital
74.10 18.97 32.11 102.72 245.42 214.39 110.64 55.59 111.74 53.07
Capital Expenditures
1.17 (15.00) (2.10) (2.93) (16.35) (7.16) (9.39) (9.36) (4.01) (10.50)
Net Current Asset Value
0.48 (55.50) (48.92) (13.84) 175.84 129.74 2.36 (10.04) 57.73 21.87
EV/EBIT
0.00 0.00 0.00 0.12 0.29 0.00 0.00 0.00 0.00 0.00
Capex to Sales
(0.02) 0.26 0.02 0.04 0.24 0.16 0.26 0.35 0.23 0.64
Net Profit Margin
(2.97%) (96.91%) (81.25%) (124.91%) (94.06%) (102.03%) (109.09%) (313.02%) (387.80%) (334.31%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
3.18 2.87 1.71 0.88 0.71 0.92 0.64 0.37 0.62 0.37
Cash ROIC
(35.21%) (73.47%) (93.97%) (59.32%) (22.73%) (19.25%) (35.70%) (60.80%) (28.16%) (26.22%)
Accounts Receivable Turnover
3.14 4.47 3.86 2.91 2.84 2.33 3.33 3.37 2.02 3.73
Accounts Payable Turnover
0.37 0.30 0.27 0.33 0.47 0.36 0.30 0.20 0.14 0.05
Inventory Turnover
1.74 1.69 1.88 2.56 5.70 12.91 13.72 14.43 19.56 4.22
Average Days of Payables
822.05 1,145.07 1,172.85 1,155.74 1,031.38 1,135.19 1,228.60 2,030.12 2,757.36 11,224.91
Days of Inventory on Hand
167.88 252.28 162.72 167.93 112.19 35.11 29.70 40.40 17.06 93.79
Average Receivables
20.17 12.90 21.87 26.07 24.23 19.54 11.00 7.98 8.53 4.42
Average Payables
56.31 69.53 85.50 94.05 68.02 40.42 34.76 30.85 25.96 17.37
Average Inventory
12.03 12.32 12.18 12.01 5.63 1.13 0.77 0.42 0.19 0.19
Average Assets
164.89 155.87 230.91 345.40 364.96 279.92 183.71 193.47 208.34 144.67
Average Common Equity
30.27 (0.03) 25.80 137.95 211.44 134.76 46.14 70.12 101.73 83.62

Fold the line items

Columns are period end dates